venBio Select Advisor

Latest statistics and disclosures from Avoro Capital Advisors's latest quarterly 13F-HR filing:

Portfolio Holdings for Avoro Capital Advisors

Companies in the Avoro Capital Advisors portfolio as of the June 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Immunomedics Common (IMMU) 18.39 $930.30M +7% 26.25M 35.44
Mirati Therapeutics Common (MRTX) 9.67 $489.42M +4% 4.29M 114.17
Horizon Therapeutics Common (HZNP) 6.59 $333.48M +31% 6.00M 55.58
Iovance Biotherapeutics Common (IOVA) 5.62 $284.41M 10.36M 27.45
Sarepta Therapeutics Common (SRPT) 5.31 $268.57M +5% 1.68M 160.34
Ascendis Pharma Sponsored ADR (ASND) 5.12 $258.82M -2% 1.75M 147.90
Biomarin Pharmaceutical Common (BMRN) 4.51 $228.18M -4% 1.85M 123.34
Argenx Se Sponsored ADR (ARGX) 4.32 $218.47M +3% 970.00k 225.23
Myokardia Common (MYOK) 3.59 $181.65M +31% 1.88M 96.62
Amicus Therapeutics Common (FOLD) 3.28 $165.88M 11.00M 15.08
Adverum Biotechnologies Common (ADVM) 3.13 $158.37M +6% 7.58M 20.88
Mersana Therapeutics Common (MRSN) 3.01 $152.10M NEW 6.50M 23.40
Karyopharm Therapeutics Common (KPTI) 2.62 $132.58M 7.00M 18.94
Constellation Pharmaceuticals Common (CNST) 2.38 $120.20M +9% 4.00M 30.05
Deciphera Pharmaceuticals Common (DCPH) 2.20 $111.08M -7% 1.86M 59.72
Adaptimmune Therapeutics Sponsored ADR (ADAP) 2.02 $102.10M NEW 10.20M 10.01
Acceleron Pharma Common (XLRN) 1.96 $99.08M +20% 1.04M 95.27
Uniqure Nv Common (QURE) 1.34 $67.59M -9% 1.50M 45.06
Relmada Therapeutics Common (RLMD) 1.26 $63.77M +23% 1.43M 44.75
Zogenix Common (ZGNX) 1.20 $60.77M -19% 2.25M 27.01
Arena Pharmaceuticals Common (ARNA) 1.18 $59.80M NEW 950.00k 62.95
Athenex Common (ATNX) 1.05 $52.98M -21% 3.85M 13.76
Allogene Therapeutics Common (ALLO) 0.96 $48.33M 1.13M 42.82
Cue Biopharma Common (CUE) 0.91 $45.83M 1.87M 24.51
Madrigal Pharmaceuticals Common (MDGL) 0.78 $39.64M 350.00k 113.25
Trillium Therapeutics Common (TRIL) 0.76 $38.43M -4% 4.75M 8.09
Avadel Pharmaceuticals Sponsored ADR (AVDL) 0.73 $36.89M +4% 4.57M 8.08
Iveric Bio Common (ISEE) 0.72 $36.21M NEW 7.10M 5.10
Xenon Pharmaceuticals Common (XENE) 0.69 $35.11M 2.80M 12.54
Marinus Pharmaceuticals Common (MRNS) 0.60 $30.38M +92% 11.96M 2.54
Aurinia Pharmaceuticals Common (AUPH) 0.54 $27.14M -3% 1.67M 16.25
Black Diamond Therapeutics Common (BDTX) 0.44 $22.13M 525.00k 42.16
Retrophin Common (RTRX) 0.42 $21.43M NEW 1.05M 20.41
Cymabay Therapeutics Common (CBAY) 0.36 $18.32M -4% 5.25M 3.49
Kura Oncology Common (KURA) 0.34 $17.11M NEW 1.05M 16.30
Avidity Biosciences Common 0.33 $16.53M NEW 585.00k 28.26
Tricida Common (TCDA) 0.33 $16.49M -56% 600.00k 27.48
Ptc Therapeutics Common (PTCT) 0.33 $16.48M -72% 324.75k 50.74
Fennec Pharmaceuticals Common (FENC) 0.28 $13.95M +50% 1.67M 8.35
Amarin Corp Sponsored ADR (AMRN) 0.27 $13.84M -33% 2.00M 6.92
Revolution Medicines Common (RVMD) 0.19 $9.60M -32% 304.00k 31.57
Biodelivery Sciences Intl Common (BDSI) 0.18 $8.87M -32% 2.03M 4.36
Cardiff Oncology Common 0.10 $5.01M NEW 1.00M 5.01
Alimera Sciences Common (ALIM) 0.05 $2.62M 416.00k 6.30

Past Filings by Avoro Capital Advisors

SEC 13F filings are viewable for Avoro Capital Advisors going back to 2014

View all past filings